&nbsp;

Drugs Used:

Quick Link(s):

Regimen Monograph

Dec 2024

Regimen

EPIRIFOS

Cancer Type:

Sarcoma,

Soft Tissue

Intent: Adjuvant

Drugs Used:

mesna,

Quick Link(s):

Regimen Monograph

Mar 2021

Regimen

CVP(PO)

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Funding:

ODB - General Benefit

cyclophosphamide - oral tablets

ODB - General Benefit

prednisone

Drugs Used:

Quick Link(s):

Regimen Monograph

Jul 2019

Regimen

TOPO

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Drugs Used:

topotecan

Quick Link(s):

Regimen Monograph

Aug 2021

Regimen

TOPO

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Drugs Used:

topotecan

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

AC

Cancer Type:

Breast

Intent: Neoadjuvant, Adjuvant

Drugs Used:

DOXOrubicin,

cyclophosphamide

Quick Link(s):

Regimen Monograph

Jun 2020

Regimen

TOPO(W)

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Drugs Used:

topotecan

Quick Link(s):

Regimen Monograph

Aug 2021

Regimen

EPIR(W)

Cancer Type:

Breast

Intent: Palliative

Drugs Used:

EPIrubicin

Quick Link(s):

Regimen Monograph

Aug 2019

Regimen

CISPRALT

Cancer Type:

Lung,

Mesothelioma (Pleural)

Intent: Palliative

Funding:

New Drug Funding Program

Raltitrexed - Advanced Malignant Pleural Mesothelioma (MPM)

Drugs Used:

raltitrexed,

CISplatin

Quick Link(s):

Regimen Monograph

Oct 2024

Regimen

CRBP

Cancer Type:

Gynecologic,

Endometrial,

Ovary,

Uterine Sarcoma,

Vulva,

Sarcoma,

Uterine

Intent: Palliative

Drugs Used:

CARBOplatin

Quick Link(s):

Regimen Monograph

Nov 2019

Regimen

DEXAPOMA

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

Exceptional Access Program

pomalidomide - For patients with relapsed and/or refractory multiple myeloma, according to specific criteria.

ODB - General Benefit

dexamethasone

Drugs Used:

pomalidomide,

dexamethasone